18 GENES FOUND
Show / hide columns
XML |
RDF |
TSV |
Page
ADORA1 Adenosine A1 receptor FDA approved drug targets Plasma membrane Tissue enhanced
ADORA2A Adenosine A2a receptor Cancer-related genes Tissue enhanced
ADORA2B Adenosine A2b receptor FDA approved drug targets Cytosol Mixed
ADORA3 Adenosine A3 receptor FDA approved drug targets Mixed
GPR174 G protein-coupled receptor 174 G-protein coupled receptors Vesicles Tissue enhanced
LTB4R Leukotriene B4 receptor G-protein coupled receptors Tissue enhanced
LTB4R2 Leukotriene B4 receptor 2 G-protein coupled receptors Nucleoplasm Tissue enhanced
P2RY1 Purinergic receptor P2Y, G-protein coupled, 1 G-protein coupled receptors Tissue enhanced
P2RY10 Purinergic receptor P2Y, G-protein coupled, 10 G-protein coupled receptors Tissue enhanced
P2RY11 Purinergic receptor P2Y, G-protein coupled, 11 G-protein coupled receptors Mixed
P2RY12 Purinergic receptor P2Y, G-protein coupled, 12 Disease related genes Tissue enriched
P2RY13 Purinergic receptor P2Y, G-protein coupled, 13 G-protein coupled receptors Tissue enhanced
P2RY14 Purinergic receptor P2Y, G-protein coupled, 14 G-protein coupled receptors Tissue enhanced
P2RY2 Purinergic receptor P2Y, G-protein coupled, 2 FDA approved drug targets Cytosol Tissue enhanced
P2RY4 Pyrimidinergic receptor P2Y, G-protein coupled, 4 G-protein coupled receptors Tissue enhanced
P2RY6 Pyrimidinergic receptor P2Y, G-protein coupled, 6 G-protein coupled receptors Tissue enhanced
P2RY8 Purinergic receptor P2Y, G-protein coupled, 8 Cancer-related genes Tissue enhanced
SPECC1L-ADORA2A SPECC1L-ADORA2A readthrough (NMD candidate) FDA approved drug targets Tissue enhanced
Page
